We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Obalon Therapeutics Inc | NASDAQ:OBLN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.05 | 2.81 | 2.87 | 0 | 01:00:00 |
Obalon now has 22 patents issued in the U.S. and 31 patents issued internationally covering the Company’s proprietary Obalon Balloon System and 24 and 55 patent applications pending in the U.S. and international territories, respectively.
“These patents add to the intellectual property portfolio covering our swallowable, gas-filled intragastric balloon system in the U.S.,” said Mark Brister, Obalon’s Chief Technology Officer. “We believe that our novel technology platform featuring the Obalon Balloon, Obalon Navigation System™, and our Obalon Touch® Inflation Dispenser significantly differentiates our product offering from liquid-filled intragastric balloons.”
About Obalon Therapeutics, Inc. Obalon Therapeutics, Inc. (NASDAQ:OBLN) is a San Diego-based company focused on developing and commercializing novel technologies for weight loss. For more information, please visit www.obalon.com.
For Obalon Therapeutics, Inc.
Investor Contact:William PlovanicPresident & Chief Financial OfficerObalon Therapeutics, Inc.Office: +1 760 607 5103wplovanic@obalon.com
1 Year Obalon Therapeutics Chart |
1 Month Obalon Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions